Home Mf Research Sbi Healthcare Opportunities Fund Regular Growth

SBI Healthcare Opportunities Fund Regular Growth

-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • SI
Fund info
NAV (as on 2026-04-02)
₹409.05 -1.47%
AUM (Fund Size)
32
Expense Ratio
N/A
Exit load
{"type":"nil","rules":[],"lock_in_days":null}
Risk
N/A
AMC
SBI Mutual Fund
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2026-03-27 ₹1,000.00 ₹970.92
-2.91 %
Two Week 2026-03-18 ₹1,000.00 ₹973.27
-2.67 %
One Month 2026-03-04 ₹1,000.00 ₹964.68
-3.53 %
Three Months 2026-01-02 ₹3,000.00 ₹2,942.21
-1.93 %
Six Months 2025-10-06 ₹6,000.00 ₹5,762.39
-3.96 %
One Year 2025-04-02 ₹12,000.00 ₹11,572.24
-3.56 %
Three Year 2023-04-03 ₹36,000.00 ₹42,417.34
17.83 %
Five Year 2021-04-05 ₹60,000.00 ₹87,417.29
45.70 %
Ten Year 2016-04-04 ₹120,000.00 ₹277,145.83
130.95 %
Since Inception 2004-12-31 ₹259,000.00 ₹1,693,703.30
553.94 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity N/A
Debt N/A
Others N/A

Sectors Holding in SBI Healthcare Opportunities Fund Regular Growth

Pharmaceuticals
111%
Healthcare
32%
Chemicals
6%
Biotechnology
7%
Sovereign
0%
Biopharmaceuticals
8%
FMCG
6%

Companies Holding in SBI Healthcare Opportunities Fund Regular Growth

Sun Pharmaceutical Industries Ltd.
13.47%
Max Healthcare Institute Ltd.
6.50%
Divi'S Laboratories Ltd.
6.20%
Cipla Ltd.
5.10%
Lupin Ltd.
4.83%
Mankind Pharma Ltd.
3.87%
Aether Industries Ltd.
3.61%
Jupiter Life Line Hospitals Ltd.
3.47%
Polymedicure Ltd.
3.32%
Krishna Institute Of Medical Sciences Ltd.
3.30%
Abbott India Ltd.
3.30%
AMI Organics Ltd.
3.27%
Fortis Healthcare Ltd.
3.18%
Alkem Laboratories Ltd.
2.80%
Laurus Labs Ltd.
2.71%
Aster Dm Healthcare Ltd.
2.68%
Torrent Pharmaceuticals Ltd.
2.67%
Gland Pharma Ltd.
2.55%
Rainbow Children'S Medicare Ltd.
2.39%
Aurobindo Pharma Ltd.
2.30%
Suven Pharmaceuticals Ltd.
1.98%
Biocon Ltd.
1.83%
Vijaya Diagnostic Centre Ltd.
1.66%
Pfizer Ltd.
1.22%
Akums Drugs & Pharmaceuticals Ltd.
1.14%
Sanofi Consumer Healthcare India Ltd.
1.03%
Gufic Biosciences Ltd.
1.00%
Concord Biotech Ltd.
0.90%
Lonza Group
5.00%
182 Day T-Bill 05.06.25
0.09%
Sun Pharmaceutical Industries Ltd
12.45%
Dr. Reddy's Laboratories Ltd
11.18%
Lupin Ltd
10.60%
Cipla Ltd
10.07%
SRL Ltd
9.53%
Aurobindo Pharma Ltd
8.50%
Biocon Ltd
8.19%
Piramal Enterprises Ltd
6.77%
Mylan NV
6.63%
Hindustan Unilever Ltd
6.35%

Risk Ratios

Std. Deviation N/A
Beta N/A
Sharpe Ratio N/A
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
N/A
Expense Ratio Direct
N/A
Lock-in Period
N/A
Fund Age
N/A
Benchmark
N/A
Fund managers
Mr. Tanmaya Desai
Over 15 years Experience

Exit load

{"type":"nil","rules":[],"lock_in_days":null}

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?